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Papillomaviruses normally replicate in stratified squamous epithelial tissues of their mammalian hosts, in
which the viral genome is found as a nuclear plasmid. Two viral proteins, E1, a helicase, and E2, a transcrip-
tional activator and plasmid maintenance factor, are known to contribute to the episomal replication of the
viral genome. Recently, our laboratory discovered that papillomaviruses can also replicate in an E1-indepen-
dent manner in mammalian cells (K. Kim and P. F. Lambert, Virology, in press; K. Kim and P. F. Lambert,
submitted for publication). In this study, we describe experiments investigating the capacity of the human
papillomavirus type 16 (HPV16) genome to replicate in yeast (Saccharomyces cerevisiae). The full-length HPV16
genome, when linked in cis to a selectable yeast marker gene, either TRP1 or URA3, could replicate stably as
an episome in yeast. The replication of papillomavirus genomes in yeast is not limited to HPV16. Bovine
papillomavirus type 1 and HPV6b, -11, -16, -18, and -31 were all capable of replicating in short-term assays over
a period of 20 cell doublings. The long-term persistence of viral episomes did not require any one viral gene,
as mutant genomes defective in single genes also replicated episomally. These results indicate that the viral
episome can replicate in the absence of the E1 DNA helicase. Similarly, E2 was also not required for replication
in yeast, and E2 mutant viral genomes were stably maintained in the absence of selection, indicating the
existence of an E2-independent mechanism for plasmid maintenance. The episomal replication of papilloma-
virus genomes in yeast provides a genetically manipulatable system in which to investigate cellular factors
required for episomal replication and may provide a novel means for generating infectious papillomavirus.
Human papillomaviruses (HPVs) infect and persist in dif-
ferentiating epithelial cells present in the cutaneous, mucosal,
and genital tissues. Papillomaviruses replicate as low-copy-
number nuclear plasmids. The life cycles of these viruses are
thought to occur in three distinct phases: establishment, in
which there is an early amplificational event; maintenance, in
which viral genomes are maintained extrachromosomally at a
constant copy number; and an amplification stage, in which the
viral copy number increases prior to encapsidation (17).
The replication of papillomaviruses involves two virally en-
coded proteins, E1, DNA helicase, and E2, a transcription and
maintenance factor. It has generally been thought that repli-
cation of papillomaviruses is dependent upon the presence of
E1 and E2 (11, 36, 46). However, our laboratory has recently
observed that bovine papillomavirus type 1 (BPV-1) and HPV
types 16, 18, and 31 (HPV16, -18, and -31) are capable of
replicating extrachromosomally in human cells in the absence
of functional E1 protein (21a; K. Kim and P. F. Lambert,
submitted for publication). We have also found that in BPV-1,
temperature-sensitive mutants of E1 are capable of stable rep-
lication at the nonpermissive temperature, further supporting
the existence of an E1-independent mode of replication (21a).
The contributions of E2 to stable replication of HPVs are not
completely understood. Recent work has implicated E2 in the
segregation of newly synthesized genomes, and this is thought
to occur by E2 tethering viral genomes to host chromosomes
during mitosis (2, 18, 26, 34, 42, 48).
Unlike more complex viruses, which carry their own poly-
merase genes, papillomaviruses rely largely on cellular repli-
cative machinery, including polymerase  (Pol) (32). The E1
protein, a DNA helicase, binds to the p70 and p180 subunits of
Pol (8). Thus, initiation at the E1-dependent origin in the
long control region (LCR) is mediated by E1 recruitment of
Pol (9, 32). This observation is supported by two-dimensional
gel analysis (13). However, our recent studies have presented
the possibility that an alternative mode of genome replication
occurs which does not involve E1. This alternative mode is
likely to require that cellular proteins substitute for E1 helicase
activity. This led us to hypothesize that the cellular origin
recognition complex (ORC) and replicative machinery medi-
ate E1-independent replication, i.e., that papillomaviruses pos-
sess autonomously replicating sequence (ARS)-like elements.
Our prior investigation of the requirements for the viral
trans-acting factor, E1, in stable replication led us to develop a
novel replication assay system based on Saccharomyces cerevi-
siae. Our rationale for developing a yeast-based system was
fourfold. (i) Cellular machinery likely to be required for pap-
illomavirus replication in human cells is highly conserved in
yeast. Although the specificities of human and yeast Pol en-
zymes differ (15), multiple components, such as proliferating
cell nuclear antigen, minichromosome maintenance (MCM)
proteins (24, 25), replication factor C (28), and replication
protein A have functionally equivalent counterparts in yeast
and mammalian cells (10, 21). (ii) ARSs in yeast share se-
quence features, such as A/T-rich clusters, with mammalian
origins (7, 31). (iii) Despite greater complexity in mammalian
cells, the ORC is functionally conserved from yeast to mam-
malian cells (7, 47). (iv) A yeast-based system would be rela-
tively easy to manipulate while providing excellent genetic
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tools with which to analyze replication of the viral genome.
Furthermore, another laboratory has successfully recreated
complex replication programs of higher eukaryotic viruses,
such as brome mosaic virus and Flockhouse virus, in S. cerivi-
siae (19, 35). Recent studies of EBNA1-dependent plasmid
maintenance demonstrate that this activity can also be mod-
eled in yeast (20). Yeast has also proven its utility in the study
of papillomavirus E2-dependent transcriptional activation
function (23, 30, 43). Thus, we tested whether HPV16 could
replicate in yeast.
In this study, full-length HPV16 was linked in cis to select-
able markers, and the recombinant plasmids were introduced
into yeast. Based on these studies, we discovered that HPV16
contains intrinsic ARS- and centromere (CEN)-like activities.
Furthermore, HPV16 was found to be capable of replicating in
yeast in the absence of E1, suggesting that the mode of repli-
cation functional in yeast is analogous to the E1-independent
mode of replication we recently discovered in mammalian cells
(Kim and Lambert, submitted). Surprisingly, we also found
that no individual gene, including the E2 gene, is required for
stable replication in yeast, suggesting that a CEN-like ele-
ment(s) in HPV16 DNA provides an E2-independent mecha-
nism for the stable inheritance of episomes in daughter cells.
Lastly, the capacity of papillomaviruses to replicate in yeast is
a general phenomenon, as multiple papillomavirus genotypes,
including BPV-1 and various anogenital papillomaviruses,
were all capable of replicating in S. cerevisiae. Stable replica-
tion of HPVs in yeast provides obvious utility as a genetic tool
in understanding the roles of cellular genes in these functions.
In addition, the potential to model specific viral functions, such
as genome amplification or encapsidation, in yeast makes this
system potentially powerful.
MATERIALS AND METHODS
Yeast strains and transformation methods. The yeast strain YPH500 (MAT
ura3-52 lys2-801 ade2-101 trp1-63 his3-200 leu2-1) used in the described
experiments was a gift from Paul Ahlquist (University of Wisconsin–-Madison
[39]). In preliminary experiments, the HF7c yeast strain (MATaura3-52 his3-200
lys2-801 ade2-101 trp1-901 leu2-3,112 gal4-542 gal80-538 LYS2::GAL-HIS3
URA3::[GAL4 17-mers]3 -CYC1-lacZ) was used (Clontech, Palo Alto, Calif.).
Yeasts were grown on minimal media omitting tryptophan (Trp) or uracil (Ura),
as needed, to select for plasmids. Plasmid DNAs were transformed into yeast
using the standard lithium chloride method (38) or the EZ Yeast Transformation
kit (Zymo Research, Orange, Calif.).
DNA constructions. The pYac plasmid (23), which contains the yeast TRP1
gene, an ARS, and a CEN element, is a modification of pYac2 (6). pYac was
modified to generate derivatives with either the ARS or the CEN element
deleted. To create a CEN derivative (pPA94), pYac was digested with SpeI
and DraIII enzymes to remove a 978-bp fragment containing the CEN element.
A linker (top, 5-GTGCAGCTCGAGTCAA-3; bottom, CTAGTTGACTCGA
GCTGCACACA) with SpeI and DraIII ends was directly ligated into the gap. To
create an ARS CEN HPV16 construct, the BglII site adjacent to the ARS
element of pPA94 was digested, and the entire HPV16 genome was excised from
pEF399 with a BamHI digest. The BamHI-ended genome was ligated directly
into the BglII site, resulting in an ARS CEN vector containing HPV16, which
was named pPA95. An ARS CEN derivative of pYac (pKT273) was created
by deleting 1,664 bp between the AatII and HpaI sites, which contains the ARS
element. A BamHI fragment containing the entire HPV16 genome (E1TTL2
[Kim and Lambert, submitted]) was ligated into the BglII site of pKT273, result-
ing in the ARS CEN HPV16 (E1TTL2) plasmid referred to as pKT274. Next,
the TRP1 gene was excised from a cloning vector (pKT268) with SpeI and AatII
digests and was cloned directly into the AatII and XbaI sites of pUC18. The
resultant vector was ARS CEN and was named pKT270. By an identical
strategy, the TRP1 gene was introduced into the pUC18 backbone of plasmids
containing wild-type (wt) (pPA100) or mutant (E1TTL2 [pKT269], E2TTL
[pPA101], E5fs [pKT304], E6TTL [pKT307], E7TTL [pKT303], L1TTL
[pKT305], or L2TTL [pKT308]) HPV16 genome.
Two HPV16-containing constructs were created from which pUC18 could be
deleted prior to the transformation of yeast. These vectors contain either TRP1
(pKT309) or URA3 (pPA103) biosynthetic markers. The pKT309 plasmid was
created by digesting pEF399 with StuI and XbaI, which removed nucleotides
4496 to 6150 from the L2 and L1 open reading frames (ORFs). The 1.7-kb
fragment was replaced with a StuI/SpeI fragment from pKT268 containing the
TRP1 gene. To create pPA103, the pEF399 clone was first digested with PmlI,
which cleaves just downstream of the L1 ORF (nucleotide 7266 of the genome).
A blunt-ended linker containing an XhoI site (top, 5-CGACTCGAGTGC-3;
bottom, 5-GCACTCGAGTCG-3) was ligated directly into the PmlI site, cre-
ating the construct referred to as pPA99. The URA3 gene was then amplified
from pRS316 using 5 (5-GATCCTCGAGGCAGATTGTACTGAGAGTG-3)
and 3 (5-ACTGCTCGAGTAGTATACATGCATTTAC-3) primers contain-
ing XhoI sites (underlined). The amplified product was digested with XhoI and
ligated into the XhoI site of pPA99, creating pPA103. A BamHI digest of either
pPA103 or pKT309 allows the 2.7-kb pUC18 backbone to be removed and the
HPV16 DNA to be religated, still retaining the selectable marker. As a negative
control for pPA103, the XhoI-digested PCR product containing the URA3 gene
was cloned into the pUC18 SalI site, creating pPA104.
Colony formation assay. Two-hundred nanograms of each of the described
plasmids was transformed into YPH500 yeast. The transformants were plated on
selective media and scored for the ability to form colonies after 3 days.
DNA isolation. Yeast cells harboring HPV16 plasmids were grown in 25-ml
cultures in selective media overnight to yield an optical density at 600 nm
(OD600) over 1.0. Typically, 5  108 cells were harvested per 25-ml culture. The
cells were pelleted and resuspended in 600 to 800 l of lysis buffer (10 mM Tris
[pH 8.0], 100 mM NaCl, 2% Triton X-100, and 1% sodium dodecyl sulfate).
Acid-washed glass beads (0.5-mm diameter; Sigma, St. Louis, Mo.) were added
to a volume of 300 l. Six-hundred microliters of phenol-chloroform was added,
and the mixture was vortexed for 1 to 2 min. The supernatants were recovered by
centrifugation and transferred to a new tube. DNA was ethanol precipitated by
the addition of 2.5 volumes of 100% ethanol. DNA samples were resuspended in
double-distilled H2O at a concentration of 1 107 to 5 107 cell equivalents per
l.
DNA replication assays. Plasmid-containing colonies were grown in contin-
uous culture on solid media for 3 weeks prior to analysis. DNA was isolated
from liquid cultures as described above. For the purpose of demonstrating
that the plasmids had replicated in yeast, the DpnI resistance assay was
performed. In this assay, bacterially methylated DNA is digested by DpnI and
thus is distinguishable from DNA synthesized in eukaryotic cells, which is
unmethylated at DpnI sites and therefore resistant to digestion (22). The
DNA samples were digested with DpnI for 24 h. Approximately 108 cell equiv-
alents of DNA was loaded on to a 1% agarose gel. The DNA was electropho-
resed, transferred to nitrocellulose, and probed with radiolabeled HPV16 DNA
(pEF399). Radiolabeling was achieved by use of the Rediprime kit (Amersham,
Piscataway, N.J.) in accordance with the manufacturer’s instructions. The repli-
cated DNAs were visualized and quantified by use of a PhosphorImager (Mo-
lecular Dynamics, San Jose, Calif.).
Short-term DNA replication assays. YPH500 yeast was transformed with 250
ng of plasmids containing the following full-length viral genomes: BPV-1 and
HPV6b, -11, -16, -18, and -31. The transformants were pelleted, inoculated
into 25 ml of yeast-peptone-dextrose medium, and cultured for 48 h (20 cell
doublings). The approximate number of cells at the time of harvest was
determined by spectrophotometer readings at OD600. Cells were collected by
centrifugation, and the cell pellet was washed with phosphate-buffered saline.
The cells were then lysed, and DNA was recovered as described previously.
The samples were spiked with 5 ng of pUC18 DNA. The DNA was resus-
pended such that the final concentration was 1  107 to 5  107 cell equiv-
alents per l. Approximately 108 cell equivalents was digested with DpnI for
24 h. The samples were loaded onto a 1% agarose gel and electrophoresed.
Southern blot analysis was performed using pUC18 as a probe so that all
genomes would be equally detected.
Plasmid stability assay. The plasmid stability experiments were performed
as described by Kapoor et al. (20). Yeast colonies harboring episomal copies of
pYac, pPA100 (wt HPV16), or pPA101 (E2TTL) were analyzed for plasmid
stability in the absence of nutritional selection. Cultures were first grown in
selective media to mid-log phase and diluted to an OD600 of 0.1 into new cultures
containing nonselective media (with Trp). The cultures were grown for 0 to 17
cell generations. The cultures at either 0 or 17 generations were diluted to an
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OD600 of 0.1 and further diluted by 10-fold serial dilutions. Five-microliter
aliquots of each dilution were spotted to selective (without Trp) and nonselective
(with Trp) media. In order to determine the percentage of cells retaining plas-
mid, equal amounts of an appropriate dilution of the cultures were plated on
selective and nonselective media and counted after 3 days of growth. The per-
centage of cells retaining plasmid was given by the ratio of the number of
colonies present on selective medium versus the number on nonselective me-
dium. The percent plasmid loss per cell generation was calculated by subtracting
the percent plasmid retained after 17 generations from the percent plasmid
retained at 0 generations and dividing by the total number of generations.
RESULTS
The HPV16 genome contains ARS- and CEN-like activities.
In order to analyze the cis-acting functions mediated by
HPV16 genomes in yeast, a series of plasmids were generated
which were either ARS CEN, ARS CEN, or ARS
CEN and which did or did not contain the full-length HPV16
genome. A Trp1 marker was present in the vector sequence of
each plasmid in order to allow selection for yeast which could
FIG. 1. The HPV16 genome can substitute for both ARS and CEN
activities of the pYac plasmid in yeast. (A) To test for maintenance
function, plasmid derivatives of pYac were created which were ARS
CEN (pPA94) or ARS CEN with the full HPV16 genome inserted
(pPA95). (B) To test for ARS activity, plasmid derivatives of pYac
were created which were ARS CEN (pKT273) or were ARS
CEN but contained either the LCR (pKT275) or the full-length viral
genome (pKT274 [E1TTL2]). (C) To test the ability of HPV16 se-
quences to provide both replication and maintenance functions, a
puc18 plasmid was created containing only the Trp1 marker (pKT270).
This vector was modified by the addition of either the LCR (pKT272)
or the full-length genome (pKT269 [E1TTL2]). The plasmid constructs
were transformed into YPH500 yeast and scored for the ability to form
colonies on selective medium. The pYac plasmid was included as a
positive control. The number of colonies obtained per microgram of
plasmid DNA is indicated below each construct. (D) Episomal repli-
cation of HPV16-containing plasmids (pPA95, pKT269 [E1TTL2], and
pKT274 [E1TTL2]). DNA isolated from yeast was electrophoresed on
a 1% agarose gel and subjected to Southern blot analysis. The blot was
probed with full-length HPV16. To the left of each blot are controls
indicating the copy number per cell. Each DNA sample was subjected
to DpnI digestion as indicated (DpnI). The arrows to the right of
each blot show the positions of open-circle (OC) and supercoiled (SC)
plasmid forms.
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stably replicate a given plasmid. These plasmids were trans-
formed into YPH500 yeast and allowed to grow for 3 days.
Whereas a plasmid which was ARS CEN (pPA94) formed
colonies extremely poorly, an ARS CEN plasmid containing
the HPV16 genome (pPA95) or an ARS CEN control plas-
mid (pYac) efficiently formed colonies (Fig. 1A). These re-
sults support the concept that the HPV16 genome can restore
maintenance function to an ARS CEN plasmid.
Whereas an ARS CEN plasmid (pYac) efficiently
formed colonies, an ARS CEN plasmid (pKT273) was un-
able to form colonies (Fig. 1B). However, the addition of
full-length HPV16 to an ARS CEN plasmid (pKT274
[E1TTL2]) restored efficient colony formation. Interestingly,
the LCR was not sufficient to rescue ARS function in the
ARS CEN plasmid (pKT275), indicating that the ARS-like
function resides outside of the LCR and E1-dependent origin
of replication in the HPV16 genome.
Not surprisingly, an ARS CEN plasmid (pKT270) lacked
the ability to form colonies, in contrast to the control ARS
CEN plasmid (pYac), while an ARS CEN plasmid con-
taining the HPV16 genome (pKT269 [E1TTL2]) was capable
of efficient colony formation (Fig. 1C). However, an ARS
CEN plasmid containing the LCR (pKT272) was not suffi-
cient to restore functions required for colony formation. These
results suggest that both replication and maintenance functions
can be provided by the HPV16 genome. Colonies derived from
these experiments were further analyzed for evidence of epi-
somal replication of the HPV16-containing plasmids.
FIG. 2. HPV16 sequence is sufficient to allow stable episomal rep-
lication of plasmids in yeast. (A) Control plasmids with a pUC18
backbone were constructed with either a TRP1 (pKT270) or a URA3
(pPA104) marker. Corresponding HPV16-containing plasmids had ei-
ther a TRP1 (pKT309) or a URA3 (pPA103) marker and were created
such that the entire pUC18 sequence could be excised prior to trans-
formation into yeast. Transformed yeasts were scored for their ability
to form colonies on selective medium. The number of colonies ob-
tained per microgram of plasmid DNA is indicated below each con-
struct. (B) Episomal replication of pPA103 and pKT309 is indicated in
the first two gels from the left. In each lane, 108 cell equivalents of
DNA was loaded. The lanes on the left of each gel are controls for the
copy number per cell. In the gel on the far right, YPH500 yeast was
transfected with full-length HPV16 from which the pUC18 vector
backbone had been excised. The yeast was grown for 36 h (approxi-
mately 15 cell doublings), and then cultures were harvested and DNA
was isolated. As a control for the completion of DpnI digestion, 2 ng of
pUC18 was added to each sample. DpnI digestion was carried out for
24 h, and samples were subjected to Southern blot analysis. The blot
was probed with full-length pUC18-HPV16 (pEF399). The arrows to
the right of each blot show the positions of open-circle (OC) and
supercoiled (SC) HPV16 plasmids, respectively. In the rightmost blot,
the position of the spiked pUC18 DNA (Spike DNA) is indicated by an
arrow. Note that pPA103, pKT309, and HPV16 migrate as lower-
molecular-weight species than their parental plasmids (shown as con-
trols), since the 2.7-kb pUC18 sequences had been deleted prior to
transformation of yeast.
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Episomally replicating HPV16 plasmids were detected re-
gardless of whether the backbone contained complementing
yeast replication or maintenance elements (Fig. 1D). There-
fore, HPV16 DNA is able to efficiently substitute for both ARS
and CEN functions. The HPV16 plasmids were present in low
copy numbers, approximately one to five copies per cell, de-
pending on the construct. In these experiments, there was no
evidence of integration of HPV16 DNA into the yeast genome,
as indicated by the resolution of a single band upon digestion
with NcoI (data not shown). Identical results were observed in
an alternative yeast strain, HF7c (data not shown).
To confirm that replication and maintenance activities were
dependent on HPV16 DNA and not on pUC18 or the marker
DNA, HPV16 plasmids, containing either a TRP1 (pKT309) or
a URA3 (pPA103) marker, were generated from which the
pUC18 sequence could be excised prior to transfection into
yeast. Both of these constructs displayed efficient colony for-
mation (Fig. 2A), whereas negative control plasmids contain-
ing pUC18 and TRP1 (pKT270) or URA3 (pPA104) failed to
form colonies. Both pPA103 and pKT309 replicated episo-
mally in yeast, as detected by Southern blotting (Fig. 2B). Both
of these plasmids have lower molecular weights than their
parental plasmids (shown as copy controls), since the 2.7-kb
pUC18 vector had been removed from each prior to the trans-
formation of yeast. To assess further the role, if any, of non-
viral sequences in supporting episomal replication, we trans-
fected the full-length religated HPV16 genomes into yeast in
short-term assays. Transformants were cultured for approxi-
mately 15 cell doublings and analyzed by Southern blotting. In
these experiments, we discovered that HPV16, released from
any vector or foreign sequence, replicated stably in yeast (Fig.
2B). In total, these results demonstrate that the HPV16 ge-
nome contains all the genetic elements necessary and sufficient
for replication and maintenance in yeast.
No single ORF tested is required for replication of HPV16 in
yeast. Several studies have indicated that virally encoded fac-
tors such as E1 and E2 are required for stable replication of
papillomaviruses (11, 36). However, recent studies from our
laboratory indicate that E1 is not strictly required for replica-
tion of BPV-1 and HPVs in mammalian cells (Kim and Lam-
bert, submitted). Therefore, we wanted to formally test which
ORFs, if any, were required for stable replication and main-
tenance of HPV16 in yeast. A series of plasmids were created
which contained the TRP1 marker and full-length viral ge-
nomes bearing mutations–-E1TTL, E2TTL, E5fs, E6TTL,
E7TTL, L1TTL, and L2TTL–-that lead to disruption of indi-
vidual ORFs due to the introduction of stop codons (transla-
tion termination linker [TTL]) or frameshifts (fs) early within
each gene. All of the mutant genomes, when transformed into
yeast, formed colonies approximately as efficiently as the wt
genome (data not shown). Southern blot analysis of yeasts
containing these mutants revealed that all were capable of
replication (Fig. 3).
HPV16 genomes display mitotic stability similar to that of
yeast CEN-containing plasmids. Newly synthesized papilloma-
virus genomes are efficiently partitioned to daughter cells dur-
ing cytokinesis. Prior studies have suggested that the BPV-1 E2
protein contributes to maintenance, perhaps through its asso-
ciation with mitotic chromosomes (34, 42); however, it is not
clear that this function of BPV-1 E2 is shared by HPV16 E2.
FIG. 3. No single ORF tested is required for episomal replication of HPV16 in yeast. Plasmid constructs which contain either the wt HPV16
genome (pPA100) or genomes with E1TTL2 (pKT269), E2TTL (pPA101), E5fs (pKT304), E6TTL (pKT307), E7TTL (pKT303), L1TTL
(pKT305), or L2TTL (pKT308) mutations were transformed into YPH500 yeast. Five colonies were pooled and analyzed for stable episomal
replication. DNA samples were DpnI digested prior to electrophoresis. The lanes on the left of the gel are controls for the copy number per cell.
The blot was probed with full-length HPV16. The arrows to the right of the blot show the positions of open-circle (OC) and supercoiled (SC)
plasmid forms. Note that the E1TTL genome replicated as efficiently as the wt in multiple experiments (Fig. 1D), and thus, the apparent reduction
in replication efficiency of E1TTL observed in this experiment was not reproducible.
3354 ANGELETTI ET AL. J. VIROL.
Since HPV16 is capable of replication in yeast independent of
any particular gene product, we questioned how stable these
genomes were in the absence of E2. Therefore, we assessed the
mitotic stabilities of wt HPV16, E2TTL, and pYac in the
absence of selection (Fig. 4A). Yeasts harboring the plasmids
were allowed to grow in the absence of selection for 0 to 17 cell
generations. At each of the time points, serial dilutions of the
cultures were plated on selective (without Trp) or nonselective
(with Trp) medium. Clearly, at either 0 or 17 cell generations,
the numbers of colonies formed on selective versus nonselec-
tive medium were very similar at each dilution tested. These
results show that very little plasmid loss had occurred over 17
cell doublings. Each plasmid showed similar stability charac-
teristics: for example, the percentage of plasmid retained after
17 cell generations in the absence of selection was 74% for
pYac, 77% for wt HPV16, and 78% for E2TTL (Fig. 4B).
Based on these results, the plasmid loss per cell generation was
calculated to be 1.5% for pYac, 1.4% for wt HPV16, and
1.1% for E2TTL. Therefore, the HPV16 genome is as stable as
a yeast CEN-containing plasmid, such as pYac. By quantita-
tive Southern blot analysis of a plasmid loss assay, it was ob-
served that episomal copies of HPV16 (pKT269) were retained
after 10 cell doublings with a loss rate of 1% per cell generation
(data not shown). These results support the concept that main-
FIG. 4. HPV16 is as mitotically stable as an ARS CEN plasmid in yeast, and E2 appears not to be required for this function. Yeasts
containing either pYac, wt HPV16 (pPA100), or HPV16 E2TTL (pPA101) were grown under nonselective conditions for 17 cell generations.
(A) After the incubation period, the cell cultures were serially diluted from 1 to 105. Equal volumes of each of the dilutions were spotted onto
selective () and nonselective () media. The result is a visual comparison which indicates the degree of plasmid stability. (B) To determine the
percentage of cells retaining plasmids, cultures grown in the absence of selection were diluted to an appropriate extent and plated on selective and
nonselective media. The percentage of cells retaining plasmids was determined by the ratio of the number of colonies present on the selective
medium versus the number on the nonselective medium. The table indicates the percentage of cells retaining plasmids for each plasmid at 0 and
17 cell generations (Gen).
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tenance of HPV episomes occurs independently of E2 and thus
is likely to be due to specific viral sequences.
BPV-1 and multiple HPVs can replicate in yeast. The results
with HPV16 described above led us to question whether other
papillomavirus genomes could replicate in yeast. In order to
address this question, we transfected BPV-1 and HPV6b, -11,
-16, -18, and -31 into YPH500 yeast and cultured the transfor-
mants for 20 cell doublings in rich medium (Fig. 5). Total DNA
was then isolated, spiked with pUC18 DNA, DpnI digested,
and analyzed by Southern blotting. Whereas bacterially syn-
thesized pUC18 DNA was completely digested by DpnI, the
papillomavirus DNAs recovered from yeast were DpnI resis-
tant. These results suggest that features shared among these
viral genomes allow the yeast replicative machinery to recog-
nize origin sequences and successfully replicate these DNAs.
DISCUSSION
The results reported here establish the novel finding that
papillomaviruses can replicate extrachromosomally in S. cer-
evisiae in the absence of complementing ARS or CEN ele-
ments (Fig. 1). Our experiments show that HPV16 plasmids
replicate stably at a copy number between one and five, similar
to a typical yeast ARS/CEN plasmid (5, 44).
Our experiments confirmed that replicative and mainte-
nance functions reside in papillomavirus DNA. Use of either a
TRP1 or a URA3 marker and removal of the pUC18 sequence
had no effect on colony formation or on episomal replication of
the constructs tested in yeast (Fig. 2). We found no evidence
for integration or rearrangement of these constructs in yeast.
Moreover, religated full-length HPV16, when introduced into
yeast, was able to replicate in short-term assays over 15 cell
doublings. In short, the behavior of HPV16 plasmids in yeast
was as reliable as that of typical ARS/CEN plasmids.
Our experiments showing replication of HPV16 E1TTL
(Fig. 1 and 3) support our previous findings that this trans-
acting factor is not strictly required for replication of papillo-
mavirus DNA in mammalian cells (21a; Kim and Lambert,
submitted). The major roles of E1 helicase in papillomavirus
replication are in the recruitment of Pol and in unwinding of
the origin (14, 32). We hypothesize that in the absence of E1,
these functions must be provided by cellular helicases. E1
hexamers form a clamp around DNA reminiscent of several
cellular helicases, for example, members of the RecQ family,
Werner’s and Bloom’s syndrome gene products (WRN and
BLM, respectively), and the MCM family of proteins (12, 27,
29, 33). A detailed mapping analysis of the E1-independent
origin sites in HPV16 utilized in yeast and in human cells will
lead to a better understanding of the functional significance of
this mode of replication.
The HPV16 mutant genomes in all of the ORFs were capa-
ble of episomal replication in yeast (Fig. 3). Of particular
interest is the fact that E2 was not required for the replication
of HPV16 in yeast, given the potential importance of E2 in the
replication and maintenance of viral genomes (18, 26, 36, 45).
Interestingly, we have found that exogenous E2 expression in
yeast enhances the copy number of HPV16 episomes 5- to
10-fold (data not shown). This result suggests that E2 might
function in yeast to support stable replication of papillomavi-
rus genomes; however, we do not know whether this effect of
E2 is due to its transcription, replication, or maintenance prop-
erties or a combination thereof.
Analysis of the mitotic stability of HPV16 in yeast revealed
that viral episomes are as stable as a typical ARS/CEN plasmid
(pYac). The mitotic stability of wt HPV16 and E2TTL plas-
mids was assessed using an assay described by Kapoor et al.
(20). The rate of plasmid loss for an ARS/CEN plasmid is
approximately 1 to 2% per cell generation (16). Very similar to
this expectation, we measured a loss rate of 1.5% for pYac.
Interestingly, both wt HPV16 and E2TTL plasmids were very
stable, having loss rates of 1.4 and 1.1% per cell generation,
respectively. These data indicate that viral episome mainte-
nance in yeast occurs independently of E2. The majority of
findings for mammalian cells indicate that E2 has an important
role in the partitioning of plasmids (2, 34, 42, 45). It is possible
that maintenance of HPV16 genomes in yeast is mediated by a
fortuitous interaction with a cellular factor. Alternatively,
there may exist cis-acting CEN-like elements in the HPV16
genome that heretofore have not been detected in mammalian
cells. This possibility is supported by evidence that a fragment
of the L2 ORF of BPV-1 can functionally substitute for a CEN
element in a yeast vector (4).
FIG. 5. BPV-1 and Multiple HPVs are efficiently replicated in
yeast. Yeast was transfected with pUC18-based plasmids containing
BPV-1 and HPV6b, -11, -16, -18, and -31. The yeast was cultured in
yeast-peptone-dextrose medium for 48 h (approximately 20 cell gen-
erations), and low-molecular-weight DNA was isolated. At the time of
DNA isolation, each sample was spiked with 2 ng of pUC18 in order
to monitor the completeness of DpnI digestion. DpnI digestion was
carried out for 24 h, and DNA samples were subjected to Southern blot
analysis using pUC18 as a probe. The lanes marked as standards were
loaded to compare the molecular weights of the transfected plasmids.
The arrows to the right of the blot show the positions of open-circle
(OC) and supercoiled (SC) plasmids. The position of bacterially syn-
thesized pUC18 DNA added to the samples (Spike DNA) is also
shown by an arrow. Note that the mobility of the recovered plasmids in
the lanes labeled “YPH500 Transformed” is retarded compared to the
standards by the presence of yeast genomic DNA.
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When linked to a selectable marker, HPV16 plasmids essen-
tially function as minichromosomes in yeast. Multiple studies
have taken advantage of episomal replication properties of
plasmids in yeast and in mammalian cells. The development of
the yeast artificial chromosome vectors represented a great
advancement in manipulating large DNA fragments in yeast
(6). Stable plasmids, such as those based on Epstein-Barr virus
OriP (49), have been employed to isolate human DNA frag-
ments which contain ARS-like activity (22). Similarly, a vector
described by Simpson et al. (40, 41) is a hybrid between an
ARS/CEN yeast artificial chromosome plasmid and an Ep-
stein-Barr virus OriP plasmid. This vector is capable of stable
episomal replication in both yeast and human cells while har-
boring more than 600 kb of foreign DNA. In future studies, we
will analyze the utility of our HPV plasmids as yeast-human
cell shuttle vectors and define the minimal sequences required
for episomal replication in yeast and human cells.
Our analyses also revealed that multiple HPVs and BPV-1
were capable of replication in yeast. In these experiments,
DpnI-resistant DNA was recovered from yeast after 20 cell
doublings (Fig. 5). During the course of our study, we learned
that another group had independently discovered that BPV-1
can replicate in S. cerevisiae (50). Our data support the idea
that sequence elements required for origin recognition in yeast
are conserved among multiple viruses. This raises the obvious
question of whether papillomavirus “origins” active in yeast
can also function in human cells? Though our data do not
address this question completely, it is interesting that, as we
found in yeast (Fig. 1), the E1-independent replication ele-
ment(s) lies outside of the LCR in mammalian cells (Kim and
Lambert, submitted). There is some evidence that ARS se-
quences have conserved determinants from yeast to humans
(1). Despite sequence differences, a comparison of replication
initiation sites of yeast ARS1 with the simian virus 40 origin
finds that leading- and lagging-strand initiation sites flanking
the origin map in similar patterns (3), suggesting conserved
recognition machinery. Furthermore, the constituents of the
ORC in mammalian cells and budding yeast have significant
homology and are thought to retain mechanistic similarity (47).
Recognition of A/T-rich clusters in the origin by ORC proteins
which contain A/T hook domains is likely to play a key role in
site recognition in yeast and mammalian cells, though the pre-
cise specificities may differ slightly (7). Thus, it is plausible that
yeast replicative machinery recognizes sequences shared
among papillomaviruses and that the same sites are potentially
utilized in both yeast and human cells.
The system we have described represents a significant ad-
vance which will aid in our understanding of papillomaviruses.
This system is ideal for analyzing the requirements for episo-
mal replication, in particular, the contributions of E1 and E2.
Regulated expression of these genes may allow the develop-
ment of a model for genome amplification. Furthermore,
yeasts provide superb genetic tools with which to dissect the
roles of cellular and viral trans-acting factors involved in ex-
trachromosomal replication. Recent work has demonstrated
that yeasts expressing HPV16 L1 and L2 allow the formation of
virus-like particles (37). Using our system, we foresee the pos-
sibility of packaging full-length HPV16 into virions.
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